This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/518656-european-leaders-astrazeneca-clotting/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
European leaders attempt to restore faith in AstraZeneca Covid vaccine by getting or promising to get jabs after blood-clot fears European leaders attempt to restore faith in AstraZeneca Covid vaccine by getting or promising to get jabs after blood-clot fears
(30 days later)
Italian PM Mario Draghi has said he will have the AstraZeneca vaccine, becoming the latest world leader to pledge their faith in the jab after the EU drugs regulator said it was safe, amid fears it may cause blood clots.Italian PM Mario Draghi has said he will have the AstraZeneca vaccine, becoming the latest world leader to pledge their faith in the jab after the EU drugs regulator said it was safe, amid fears it may cause blood clots.
“Yes, I will do the AstraZeneca vaccine,” the prime minister said on Friday during his first news conference since entering office last month. “Yes, I will do the AstraZeneca vaccine,” the prime minister said on Friday during his first news conference since entering office last month. 
Italy was among a dozen EU countries to temporarily ditch the vaccine after confidence in the jab was shattered by reports from Austria that a person who took it had died from blood clotting and another was hospitalized. Italy was among a dozen EU countries to temporarily ditch the vaccine after confidence in the jab was shattered by reports from Austria that a person who took it had died from blood clotting and another was hospitalized. 
But multiple EU member states quickly announced they would resume their rollouts of AstraZeneca doses on Thursday following a review by the European Medicines Agency (EMA) that found it to be safe and effective.But multiple EU member states quickly announced they would resume their rollouts of AstraZeneca doses on Thursday following a review by the European Medicines Agency (EMA) that found it to be safe and effective.
In a bid to bolster public confidence, the prime ministers of the UK and France, Boris Johnson and Jean Castex, both received their pre-arranged AstraZeneca injections on Friday.In a bid to bolster public confidence, the prime ministers of the UK and France, Boris Johnson and Jean Castex, both received their pre-arranged AstraZeneca injections on Friday.
German Chancellor Angela Merkel told a news conference that she would also roll up her sleeve for the Anglo-Swedish jab but would “wait her turn.”German Chancellor Angela Merkel told a news conference that she would also roll up her sleeve for the Anglo-Swedish jab but would “wait her turn.”
France’s drugs regulator has remained cautious by only recommending the vaccine be administered to people aged 55 and over from Friday, due to blood clots being  reported in younger people who’ve received it.France’s drugs regulator has remained cautious by only recommending the vaccine be administered to people aged 55 and over from Friday, due to blood clots being  reported in younger people who’ve received it.
Finland has suspended its rollout of the jab altogether “until there is more information,” its public health authority said on Friday, while its Scandinavian neighbours Norway, Sweden and Denmark have said they will not resume their rollouts yet. Finland has suspended its rollout of the jab altogether “until there is more information,” its public health authority said on Friday, while its Scandinavian neighbours Norway, Sweden and Denmark have said they will not resume their rollouts yet. 
The EMA said on Thursday that the AstraZeneca vaccine is “not associated with an increase in the overall risk of blood clots” – known as “thromboembolic events.”The EMA said on Thursday that the AstraZeneca vaccine is “not associated with an increase in the overall risk of blood clots” – known as “thromboembolic events.”
However, the regulator did issue a caveat that the jab may be associated with “rare cases” of blood clots in multiple blood vessels (DIC) and clotting in vessels preventing blood draining from the brain (CVST).However, the regulator did issue a caveat that the jab may be associated with “rare cases” of blood clots in multiple blood vessels (DIC) and clotting in vessels preventing blood draining from the brain (CVST).
Of the 20 million people to have received the jab in the UK and EEA as of March 16, seven cases of DIC-type clotting and 18 cases of CVST have been witnessed, the EMA said.Of the 20 million people to have received the jab in the UK and EEA as of March 16, seven cases of DIC-type clotting and 18 cases of CVST have been witnessed, the EMA said.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.